Cytrellis Biosystems
1 known investors
Cytrellis develops medical device technologies focused on aesthetic and reconstructive treatments, with expertise spanning dermatology, plastic surgery, and wound healing applications.
BiotechHealthtechMedical Devices
Founders & leadership
DD
Denise Dajles, PhDPresident & CEO
RA
Rox Anderson, MDFounder, Medical / Technology Advisor
WG
William G. Austen, Jr. MDFounder, Medical / Technology Advisor
DL
Doug Levinson, PhDFounder
Investors · 1
In the news
- Cytrellis Biosystems launches Updated Next-Generation Skin Removal Treatment ellacor® 2.0, fueled by new leadership and financingglobenewswire.com · 2025
- Cytrellis Biosystems 9/22/2021 Capital Raise - Gaebler.com Venture Capital Databasegaebler.com · 2021
- Cytrellis Biosystems Completes $50 Million Series C Financingprnewswire.com · 2021
- Cytrellis - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Cytrellis Biosystems Raises $28.5M in Series B Financing - FinSMEsfinsmes.com · 2018
- Merz Venture Initiative Increases Investment in Cytrellis - Merz Pharmareinheim.merz.com